DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $742,316 | +3.4% | 2,992 | 0.0% | 0.20% | +7.7% |
Q2 2023 | $718,080 | -5.9% | 2,992 | -1.2% | 0.18% | 0.0% |
Q1 2023 | $762,926 | -3.9% | 3,027 | +1.2% | 0.18% | -4.2% |
Q4 2022 | $794,137 | +2.7% | 2,992 | 0.0% | 0.19% | -13.6% |
Q3 2022 | $773,000 | +1.8% | 2,992 | 0.0% | 0.22% | -8.7% |
Q2 2022 | $759,000 | -13.6% | 2,992 | 0.0% | 0.24% | +1.7% |
Q1 2022 | $878,000 | -10.8% | 2,992 | 0.0% | 0.24% | -9.2% |
Q4 2021 | $984,000 | +8.0% | 2,992 | 0.0% | 0.26% | -3.3% |
Q3 2021 | $911,000 | +13.4% | 2,992 | 0.0% | 0.27% | +13.0% |
Q2 2021 | $803,000 | +19.3% | 2,992 | 0.0% | 0.24% | +13.8% |
Q1 2021 | $673,000 | +1.2% | 2,992 | 0.0% | 0.21% | -4.1% |
Q4 2020 | $665,000 | +3.3% | 2,992 | 0.0% | 0.22% | +6.3% |
Q3 2020 | $644,000 | +21.7% | 2,992 | 0.0% | 0.21% | +76.1% |
Q2 2020 | $529,000 | +30.0% | 2,992 | +1.8% | 0.12% | -4.9% |
Q1 2020 | $407,000 | -10.7% | 2,940 | -0.9% | 0.12% | -38.5% |
Q4 2019 | $456,000 | -1.3% | 2,968 | -7.2% | 0.20% | -13.8% |
Q3 2019 | $462,000 | +1.1% | 3,200 | 0.0% | 0.23% | -2.1% |
Q2 2019 | $457,000 | +8.3% | 3,200 | 0.0% | 0.24% | +6.8% |
Q1 2019 | $422,000 | +17.5% | 3,200 | -3.0% | 0.22% | +22.7% |
Q4 2018 | $359,000 | 0.0% | 3,300 | 0.0% | 0.18% | 0.0% |
Q3 2018 | $359,000 | +9.5% | 3,300 | -0.8% | 0.18% | +2.3% |
Q2 2018 | $328,000 | +0.6% | 3,328 | 0.0% | 0.18% | -5.9% |
Q1 2018 | $326,000 | +5.5% | 3,328 | 0.0% | 0.19% | +4.4% |
Q4 2017 | $309,000 | +8.4% | 3,328 | 0.0% | 0.18% | +3.4% |
Q3 2017 | $285,000 | +2.5% | 3,328 | +0.8% | 0.17% | -2.2% |
Q2 2017 | $278,000 | +8.2% | 3,300 | +10.0% | 0.18% | +2.9% |
Q1 2017 | $257,000 | -34.8% | 3,000 | -40.7% | 0.17% | -34.5% |
Q4 2016 | $394,000 | – | 5,063 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |